Mortality News and Research

RSS
Elorac's naloxone lotion receives FDA Orphan Drug Designation for pruritus associated with mycosis fungoides

Elorac's naloxone lotion receives FDA Orphan Drug Designation for pruritus associated with mycosis fungoides

Ikaria initiates enrollment in LUCASSIN Phase III trial for HRS Type 1

Ikaria initiates enrollment in LUCASSIN Phase III trial for HRS Type 1

Keryx announces positive top-line results from Zerenex Phase 3 study for hyperphosphatemia

Keryx announces positive top-line results from Zerenex Phase 3 study for hyperphosphatemia

Increased staffing enhances patient survival in medical ICU

Increased staffing enhances patient survival in medical ICU

Siemens to distribute Rcadia's COR Analyzer System

Siemens to distribute Rcadia's COR Analyzer System

Most 'worried well' groups at risk of liver disease

Most 'worried well' groups at risk of liver disease

UMDNJ researchers develop comprehensive strategy for recovery from smoking addiction

UMDNJ researchers develop comprehensive strategy for recovery from smoking addiction

Collective efforts in transplantation reduces risk of treatment-related complications in blood cancer

Collective efforts in transplantation reduces risk of treatment-related complications in blood cancer

LCA calls for public discussion on guidance for lung cancer screening

LCA calls for public discussion on guidance for lung cancer screening

New Colorectal Cancer Screening program in Quebec

New Colorectal Cancer Screening program in Quebec

Experience of ill health associated with reduction or cessation of alcohol consumption

Experience of ill health associated with reduction or cessation of alcohol consumption

Budapest meeting to highlight discrepancies in using implantable devices among European countries

Budapest meeting to highlight discrepancies in using implantable devices among European countries

Early diagnosis and treatment result in positive outcomes for RA patients

Early diagnosis and treatment result in positive outcomes for RA patients

Erbitux development program featured in ASCO's Clinical Cancer Advances report for third consecutive year

Erbitux development program featured in ASCO's Clinical Cancer Advances report for third consecutive year

Landmark comparative study supports more frequent hemodialysis

Landmark comparative study supports more frequent hemodialysis

U.S mortality rate from congenital heart defects drops 24%: Report

U.S mortality rate from congenital heart defects drops 24%: Report

Frequent hemodialysis improves left ventricular mass, physical health than conventional treatment

Frequent hemodialysis improves left ventricular mass, physical health than conventional treatment

Largest genomic study of human medulloblastomas

Largest genomic study of human medulloblastomas

Preclinical trial shows Chimerix’s CMX001 inhibits HSV replication

Preclinical trial shows Chimerix’s CMX001 inhibits HSV replication

Interim results from H.P. Acthar Gel study in patients with advanced diabetic nephropathy

Interim results from H.P. Acthar Gel study in patients with advanced diabetic nephropathy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.